AG001C87

14028-44-5 | 2-Chloro-11-(1-piperazinyl)dibenz[b,f][1,4]oxazepine

Chemical structure of 2-Chloro-11-(1-piperazinyl)dibenz[b,f][1,4]oxazepine, CAS 14028-44-5
AG001C87
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 14028-44-5
Catalog Number AG001C87(AGN-PC-07Y4AS)
Chemical Name 2-Chloro-11-(1-piperazinyl)dibenz[b,f][1,4]oxazepine
EC Number 237-867-1
IUPAC Name 8-chloro-6-piperazin-1-ylbenzo[b][1,4]benzoxazepine
InChI InChI=1S/C17H16ClN3O/c18-12-5-6-15-13(11-12)17(21-9-7-19-8-10-21)20-14-3-1-2-4-16(14)22-15/h1-6,11,19H,7-10H2
InChI Key QWGDMFLQWFTERH-UHFFFAOYSA-N
MDL Number MFCD00069210
Molecular Formula C17H16ClN3O
Molecular Weight 313.7814
NSC Number 759559
SMILES Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1
UNII R63VQ857OT
Synonyms
2-Chloro-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepine, Amoxapine, Asendin, Asendis, CL 67,772, CL-67,772, CL67,772, Défanyl, Demolox, Desmethylloxapine, amoxapine, 14028-44-5, Asendin, Demolox, Moxadil, Amoxan, Amoxapinum, Amoxapina, Amoxepine, Asendis, Desmethylloxapin, Ascendin, Amoxapinum [INN-Latin], Amoxapina [INN-Spanish], CL 67772, 2-Chloro-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepine, Dibenz[b,f][1,4]oxazepine, 2-chloro-11-(1-piperazinyl)-, UNII-R63VQ857OT, CL-67772, EINECS 237-867-1, MFCD00069210, BRN 0832057, C17H16ClN3O, CHEMBL1113, 2-Chlor-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepin, 2-Chloro-11-(1-piperazinyl)dibenz[b,f][1,4]oxazepine, MLS000069371, 2-chloro-11-(piperazin-1-yl)dibenzo[b,f][1,4]oxazepine, CHEBI:2675, R63VQ857OT, QWGDMFLQWFTERH-UHFFFAOYSA-N, Desmethylloxapine, DIBENZ(b,f)(1,4)OXAZEPINE, 2-CHLORO-11-(1-PIPERAZINYL)-, 8-chloro-6-piperazin-1-ylbenzo[b][1,4]benzoxazepine, 2-chloro-11-piperazin-1-yldibenzo[b,f][1,4]oxazepine, NCGC00015004-09, CPD000058416, Defanyl, SMR000058416, CAS-14028-44-5, DSSTox_CID_2598, DSSTox_RID_76652, DSSTox_GSID_22598, 8-chloro-6-piperazin-1-yl-benzo[b][1,4]benzoxazepine, (E)-2-chloro-11-(piperazin-1-yl)dibenzo[b,f][1,4]oxazepine, 13-chloro-10-(piperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene, Asendin (TN), Amoxapine [USAN:BAN:INN:JAN], SR-01000003001, amoxipine, Amoxapin, CL-67,772, Prestwick_503, Amoxapine [USAN:USP:INN:BAN:JAN], KS-1197, Opera_ID_33, Spectrum_000446, Lopac-A-129, CL 67,772, Prestwick0_000102, Prestwick1_000102, Prestwick2_000102, Prestwick3_000102, Spectrum2_001245, Spectrum3_001067, Spectrum4_001218, Spectrum5_001284, A-129, AC1L1D2U, Lopac0_000116, REGID_for_CID_2170, SCHEMBL33950, BSPBio_000084, BSPBio_002654, GTPL201, KBioGR_001656, KBioSS_000926, ZINC931, DivK1c_000236, SPECTRUM2300161, SPBio_001150, SPBio_002023, Amoxapine (JP17/USP/INN), BPBio1_000094, 2-Chloro-11-(1-piperazinyl)dibenzo[b,f][1,4]oxazepine, DTXSID7022598, BDBM22870, CTK8F7751, HMS500L18, KBio1_000236, KBio2_000926, KBio2_003494, KBio2_006062, KBio3_001874, 2-Chloro-11-(1-piperazinyl)-dibenz[b,f][1,4]oxazepine, NINDS_000236, HMS1568E06, HMS2089G10, HMS2093N08, HMS2095E06, HMS2231E13, HMS3259G08, HMS3260G14, HMS3370P03, HMS3712E06, Pharmakon1600-02300161, HY-B0991, KS-000014ZS, Tox21_110064, Tox21_302352, Tox21_500116, ABP000992, BG0035, CCG-39135, NSC759559, PDSP1_001609, PDSP2_001593, s4218, AKOS015895092, Tox21_110064_1, AC-5495, CS-4485, DB00543, LP00116, MCULE-9583761109, NC00546, NSC-759559, VA10272, IDI1_000236, NCGC00015004-01, NCGC00015004-02, NCGC00015004-03, NCGC00015004-04, NCGC00015004-05, NCGC00015004-06, NCGC00015004-07, NCGC00015004-08, NCGC00015004-10, NCGC00015004-11, NCGC00015004-13, NCGC00015004-16, NCGC00023887-03, NCGC00023887-04, NCGC00023887-05, NCGC00023887-06, NCGC00255124-01, NCGC00260801-01, AN-10914, BC657161, LS-61563, O286, SAM002564189, SC-79931, SBI-0050104.P003, AK01050722, EU-0100116, FT-0659871, A16406, D00228, AB00052421-13, AB00052421_14, AB00052421_15, 028A445, A807639, C-54133, L001293, I06-0520, J-007373, SR-01000003001-2, SR-01000003001-4, SR-01000003001-6, 8-chloro-6-piperazin-1-ylbenzo[b][1,5]benzoxazepine, BRD-K02265150-001-05-9, BRD-K02265150-001-15-8, 2-Chloro-11-(1-piperazinyl)dibenz[b,f]-1,4-oxazepine, 2-Chloro-11-(1-piperazinyl)dibenzo[b,f]-1,4-oxazepine, 2-Chloro-11-piperazin-1-yl-dibenzo[b,f][1,4]oxazepine, 8-chloro-6-(1-piperazinyl)benzo[b][1,4]benzoxazepine, Z1551429736, 2-Chloro-11-(1-piperazinyl)- dibenz[b,f][1,4]oxazepine, 2-Chloro-11-(1-piperazinyl)dibenzo[b,f][1,4]oxazepine #, 8-chloranyl-6-piperazin-1-yl-benzo[b][1,4]benzoxazepine, Amoxapine, 1.0 mg/mL in methanol, certified reference material, Amoxapine, United States Pharmacopeia (USP) Reference Standard, Dibenzo[b,f][1,4]oxazepine, 2-chloro-11-(1-piperazinyl)-, Amoxapine, Pharmaceutical Secondary Standard; Certified Reference Material, 13-chloro-10-(piperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0;{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene, 13-chloro-10-(piperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,9,12,14-heptaene, Amoxapine-d8, Asendis (TN), Defanyl (TN), Demolox (TN), Moxadil (TN), D09IOI, Amoxapine (JP15/USP/INN), C17-H16-Cl-N3-O, CID2170, Amoxapine [USAN:INN:BAN:JAN], AC-814, CS-O-05678, CL67,772, A2499, B1660, D000657, Dibenzo [b, f] [1,4] oxazepina, 2-cloro-11-(1-piperazinil)-,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited